Teva Pharmaceutical Industries Limited (BVMF:T1EV34)

BVMF:T1EV34 Statistics

Total Valuation

BVMF:T1EV34 has a market cap or net worth of BRL 208.25 billion. The enterprise value is 279.64 billion.

Market Cap	208.25B
Enterprise Value	279.64B

Important Dates

The last earnings date was Wednesday, January 28, 2026.

Earnings Date	Jan 28, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+2.83%
Shares Change (QoQ)	+0.77%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	1.15B

Valuation Ratios

The trailing PE ratio is 26.81 and the forward PE ratio is 12.70.

PE Ratio	26.81
Forward PE	12.70
PS Ratio	2.19
PB Ratio	4.78
P/TBV Ratio	n/a
P/FCF Ratio	32.93
P/OCF Ratio	22.93
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 10.49, with an EV/FCF ratio of 44.22.

EV / Earnings	36.01
EV / Sales	3.10
EV / EBITDA	10.49
EV / EBIT	13.51
EV / FCF	44.22

Financial Position

The company has a current ratio of 1.04, with a Debt / Equity ratio of 2.18.

Current Ratio	1.04
Quick Ratio	0.54
Debt / Equity	2.18
Debt / EBITDA	3.39
Debt / FCF	15.01
Interest Coverage	4.31

Financial Efficiency

Return on equity (ROE) is 20.79% and return on invested capital (ROIC) is 18.08%.

Return on Equity (ROE)	20.79%
Return on Assets (ROA)	6.17%
Return on Invested Capital (ROIC)	18.08%
Return on Capital Employed (ROCE)	14.48%
Weighted Average Cost of Capital (WACC)	6.73%
Revenue Per Employee	2.97M
Profits Per Employee	242,636
Employee Count	37,000
Asset Turnover	0.43
Inventory Turnover	2.69

Taxes

Income Tax	-991.44M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +84.24% in the last 52 weeks. The beta is 0.66, so BVMF:T1EV34's price volatility has been lower than the market average.

Beta (5Y)	0.66
52-Week Price Change	+84.24%
50-Day Moving Average	68.14
200-Day Moving Average	54.89
Relative Strength Index (RSI)	68.30
Average Volume (20 Days)	659

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	3.07

Income Statement

In the last 12 months, BVMF:T1EV34 had revenue of BRL 95.06 billion and earned 7.77 billion in profits. Earnings per share was 6.66.

Revenue	95.06B
Gross Profit	49.23B
Operating Income	21.77B
Pretax Income	6.81B
Net Income	7.77B
EBITDA	27.29B
EBIT	21.77B
Earnings Per Share (EPS)	6.66

Balance Sheet

The company has 19.59 billion in cash and 94.90 billion in debt, with a net cash position of -75.32 billion.

Cash & Cash Equivalents	19.59B
Total Debt	94.90B
Net Cash	-75.32B
Net Cash Per Share	n/a
Equity (Book Value)	43.59B
Book Value Per Share	37.89
Working Capital	2.70B

Cash Flow

In the last 12 months, operating cash flow was 9.08 billion and capital expenditures -2.76 billion, giving a free cash flow of 6.32 billion.

Operating Cash Flow	9.08B
Capital Expenditures	-2.76B
Free Cash Flow	6.32B
FCF Per Share	n/a

Margins

Gross margin is 51.79%, with operating and profit margins of 22.90% and 8.17%.

Gross Margin	51.79%
Operating Margin	22.90%
Pretax Margin	7.17%
Profit Margin	8.17%
EBITDA Margin	28.71%
EBIT Margin	22.90%
FCF Margin	6.65%

Dividends & Yields

BVMF:T1EV34 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.83%
Shareholder Yield	-2.83%
Earnings Yield	3.73%
FCF Yield	3.04%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BVMF:T1EV34 has an Altman Z-Score of 0.68 and a Piotroski F-Score of 8. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.68
Piotroski F-Score	8